Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network
[Display omitted] Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorab...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 24; no. 16; pp. 3513 - 3520 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
15.08.2016
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [Display omitted]
Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorable physicochemical properties, including molecular weight, polarity and number of hydrogen bond donors, which determines poor cell permeability. Here we describe the first systematic study of single and multiple N-methylations of OT and their effect on physicochemical properties as well as potency at the OT receptor. The agonist EC50 and percent effect for OTR are reported and show that most N-methylations are tolerated but with some loss in potency compared to OT. The effect of N-methylation on exposed polarity is assessed through the EPSA chromatographic method and the results validated against NMR temperature coefficient experiments and the determination of NMR solution structures. We found that backbone methylation of residues not involved in IMHB and removal of the N-terminal amine can significantly reduce the exposed polarity of peptides, and yet retain a significant OTR agonist activity. The results of this study also expose the potential challenge of using the N-methylation strategy for the OT system; while exposed polarity is reduced, in some cases backbone methylation produces a significant conformational change that compromises agonist activity. The data presented provides useful insights on the SAR of OT and suggests future design strategies that can be used to develop more permeable OTR agonists based on the OT framework. |
---|---|
AbstractList | [Display omitted]
Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorable physicochemical properties, including molecular weight, polarity and number of hydrogen bond donors, which determines poor cell permeability. Here we describe the first systematic study of single and multiple N-methylations of OT and their effect on physicochemical properties as well as potency at the OT receptor. The agonist EC50 and percent effect for OTR are reported and show that most N-methylations are tolerated but with some loss in potency compared to OT. The effect of N-methylation on exposed polarity is assessed through the EPSA chromatographic method and the results validated against NMR temperature coefficient experiments and the determination of NMR solution structures. We found that backbone methylation of residues not involved in IMHB and removal of the N-terminal amine can significantly reduce the exposed polarity of peptides, and yet retain a significant OTR agonist activity. The results of this study also expose the potential challenge of using the N-methylation strategy for the OT system; while exposed polarity is reduced, in some cases backbone methylation produces a significant conformational change that compromises agonist activity. The data presented provides useful insights on the SAR of OT and suggests future design strategies that can be used to develop more permeable OTR agonists based on the OT framework. Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorable physicochemical properties, including molecular weight, polarity and number of hydrogen bond donors, which determines poor cell permeability. Here we describe the first systematic study of single and multiple N-methylations of OT and their effect on physicochemical properties as well as potency at the OT receptor. The agonist EC50 and percent effect for OTR are reported and show that most N-methylations are tolerated but with some loss in potency compared to OT. The effect of N-methylation on exposed polarity is assessed through the EPSA chromatographic method and the results validated against NMR temperature coefficient experiments and the determination of NMR solution structures. We found that backbone methylation of residues not involved in IMHB and removal of the N-terminal amine can significantly reduce the exposed polarity of peptides, and yet retain a significant OTR agonist activity. The results of this study also expose the potential challenge of using the N-methylation strategy for the OT system; while exposed polarity is reduced, in some cases backbone methylation produces a significant conformational change that compromises agonist activity. The data presented provides useful insights on the SAR of OT and suggests future design strategies that can be used to develop more permeable OTR agonists based on the OT framework. Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorable physicochemical properties, including molecular weight, polarity and number of hydrogen bond donors, which determines poor cell permeability. Here we describe the first systematic study of single and multiple N-methylations of OT and their effect on physicochemical properties as well as potency at the OT receptor. The agonist EC50 and percent effect for OTR are reported and show that most N-methylations are tolerated but with some loss in potency compared to OT. The effect of N-methylation on exposed polarity is assessed through the EPSA chromatographic method and the results validated against NMR temperature coefficient experiments and the determination of NMR solution structures. We found that backbone methylation of residues not involved in IMHB and removal of the N-terminal amine can significantly reduce the exposed polarity of peptides, and yet retain a significant OTR agonist activity. The results of this study also expose the potential challenge of using the N-methylation strategy for the OT system; while exposed polarity is reduced, in some cases backbone methylation produces a significant conformational change that compromises agonist activity. The data presented provides useful insights on the SAR of OT and suggests future design strategies that can be used to develop more permeable OTR agonists based on the OT framework. (C) 2016 Published by Elsevier Ltd. |
Author | Sciabola, Simone Rogers, Bruce N. Fonseca, Kari R. Duplantier, Allen Kablaoui, Natasha M. Gray, David L. Goetz, Gilles H. Bai, Guoyun Vanase-Frawley, Michelle A. |
Author_xml | – sequence: 1 givenname: Simone surname: Sciabola fullname: Sciabola, Simone organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA – sequence: 2 givenname: Gilles H. surname: Goetz fullname: Goetz, Gilles H. organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA – sequence: 3 givenname: Guoyun surname: Bai fullname: Bai, Guoyun organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA – sequence: 4 givenname: Bruce N. surname: Rogers fullname: Rogers, Bruce N. organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA – sequence: 5 givenname: David L. surname: Gray fullname: Gray, David L. organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA – sequence: 6 givenname: Allen surname: Duplantier fullname: Duplantier, Allen organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA – sequence: 7 givenname: Kari R. surname: Fonseca fullname: Fonseca, Kari R. organization: Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, Cambridge, MA 02139, USA – sequence: 8 givenname: Michelle A. surname: Vanase-Frawley fullname: Vanase-Frawley, Michelle A. organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA – sequence: 9 givenname: Natasha M. surname: Kablaoui fullname: Kablaoui, Natasha M. email: Natasha.M.Kablaoui@pfizer.com organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27297999$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUuP0zAURi00iOkM_AA2yEsklHKdhxPDalTxGGkEC2BtOfZN65LYxXYY8u9xaZklYuPH1fmu7HOvyIXzDgl5zmDNgPHX-3U_6XWZj2to1sDLR2TFal4XVSXYBVmB4F0BneCX5CrGPQCUtWBPyGXZlqIVQqzI7ssSE04qWU0_FROm3TLmi3fUD9T_WpLX1r2ht9NB6URz-bBTYVLaj367UOUMtS4FNfkR9TyqQHeLCX6LjvbeGeu21GG69-H7U_J4UGPEZ-f9mnx7_-7r5mNx9_nD7ebmrtA1E6kYeigV9By1FspwOC5GDVVj6r6GthuYUJ1ucqEWujJmUNCxpuTQdZkpdXVNXp76HoL_MWNMcrJR4zgqh36OknXQtJyLlmeUnVAdfIwBB3kIdlJhkQzkUbDcyyxYHgVLaGQWnDMvzu3nfkLzkPhrNAOvTsA99n6I2qLT-IDlEVT5Aaxpj8OATHf_T29s-jOajZ9dytG3pyhmmz8tBnmOGxtQJ2m8_cc_fgM5ZLBa |
CitedBy_id | crossref_primary_10_1021_acsmedchemlett_2c00455 crossref_primary_10_1016_j_scitotenv_2021_148034 crossref_primary_10_1038_s41467_018_07616_w crossref_primary_10_3390_ijms222112077 crossref_primary_10_1002_med_21562 crossref_primary_10_1021_acsmedchemlett_0c00581 crossref_primary_10_1021_acs_jmedchem_7b01028 crossref_primary_10_1016_j_drudis_2020_01_012 crossref_primary_10_1021_acs_jafc_3c00877 crossref_primary_10_1002_chem_202300753 crossref_primary_10_1021_acs_jmedchem_2c00094 crossref_primary_10_1002_prp2_290 crossref_primary_10_1016_j_jbc_2022_101656 crossref_primary_10_1021_acs_jmedchem_8b01691 crossref_primary_10_1021_acs_jmedchem_9b01862 crossref_primary_10_1080_26395940_2023_2242701 crossref_primary_10_1016_j_bmcl_2017_12_027 crossref_primary_10_1016_j_biopha_2020_109832 crossref_primary_10_1021_acs_jmedchem_3c02332 crossref_primary_10_1039_C7MD00101K |
Cites_doi | 10.1016/j.psyneuen.2009.06.016 10.1021/ml500239m 10.1016/j.neuron.2008.04.009 10.1016/j.psyneuen.2009.04.002 10.1517/17425247.2011.633508 10.1002/bdd.750 10.1021/jm401859b 10.1002/mrc.2557 10.1038/sj.npp.1300021 10.1371/journal.pone.0001128 10.1126/science.1189047 10.1021/acs.jmedchem.5b00128 10.1039/c1md00093d 10.1021/ar8000603 10.1021/jm049205z 10.1021/ja303200d 10.1016/j.biopsych.2010.04.039 10.1021/cb300515u 10.1111/cbdd.12055 10.1002/jps.20125 10.1517/17425247.2011.588204 10.1002/anie.200705797 10.1002/prot.20033 10.1016/j.biopsych.2006.05.030 10.1016/j.yfrne.2011.07.001 10.1021/mp1003306 10.1016/0165-1781(93)90035-F 10.1046/j.1365-4362.36.s1.2.x 10.1021/ja00724a016 10.2174/0929866053765752 10.1021/bi00240a030 10.1016/S0021-9258(19)83740-7 10.1073/pnas.66.1.111 10.1126/science.3008332 10.1002/hlca.19850680319 10.1016/S0021-9258(18)64530-2 10.1016/0898-5529(90)90156-3 10.1007/BF00198370 10.2165/00063030-200519030-00003 10.1002/bip.360321203 10.1073/pnas.68.5.956 10.1021/bi00614a014 |
ContentType | Journal Article |
Copyright | 2016 Copyright © 2016. Published by Elsevier Ltd. |
Copyright_xml | – notice: 2016 – notice: Copyright © 2016. Published by Elsevier Ltd. |
DBID | 1KM BLEPL DTL GYFQL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.bmc.2016.05.062 |
DatabaseName | Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science - Science Citation Index Expanded - 2016 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE Web of Science MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Chemistry |
EISSN | 1464-3391 |
EndPage | 3520 |
ExternalDocumentID | 10_1016_j_bmc_2016_05_062 27297999 000380515700020 S0968089616304060 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABYKQ ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM LCYCR LZ2 M29 M2Z M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPC SPCBC SSH SSK SSP SSU SSZ T5K UPT XPP YK3 ~02 ~G- 1KM AAXKI AKRWK BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED CGR CUY CVF ECM EIF NPM 53G AAQXK AAYXX ABXDB ACNNM ACRPL ADMUD ADNMO AFFNX AFJKZ AGHFR AGRDE ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HEA HMK HMO HMS HMT HVGLF HZ~ R2- SAE SCB SEW SOC SPT WUQ ZMT 7X8 |
ID | FETCH-LOGICAL-c419t-fb02a0b6ecc9ad609ad6daf35d4b4078f19a8c5f3549c3ddfa08152608835d2c3 |
IEDL.DBID | AIKHN |
ISICitedReferencesCount | 24 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000380515700020 |
ISSN | 0968-0896 |
IngestDate | Sat Oct 26 01:14:22 EDT 2024 Fri Dec 06 01:19:00 EST 2024 Sat Sep 28 08:50:38 EDT 2024 Fri Dec 13 17:54:09 EST 2024 Tue Sep 17 23:02:33 EDT 2024 Fri Feb 23 02:30:58 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 16 |
Keywords | Hidden polarity SFC NMR Cyclic peptide Oxytocin SPPS Polarity FLIPR Intramolecular hydrogen bond Hydrogen bonding Peptide Mpa PERMEABILITY HUMANS INTRANASAL DELIVERY CONFORMATION CYCLIC-PEPTIDES HIGHLY POTENT ANALOGUE PEPTIDE-HORMONE-OXYTOCIN ORAL BIOAVAILABILITY DIMETHYL-SULFOXIDE |
Language | English |
License | Copyright © 2016. Published by Elsevier Ltd. |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c419t-fb02a0b6ecc9ad609ad6daf35d4b4078f19a8c5f3549c3ddfa08152608835d2c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5316-1586 0000-0001-6524-9278 |
PMID | 27297999 |
PQID | 1805766976 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | webofscience_primary_000380515700020 webofscience_primary_000380515700020CitationCount proquest_miscellaneous_1805766976 crossref_primary_10_1016_j_bmc_2016_05_062 elsevier_sciencedirect_doi_10_1016_j_bmc_2016_05_062 pubmed_primary_27297999 |
PublicationCentury | 2000 |
PublicationDate | 2016-08-15 |
PublicationDateYYYYMMDD | 2016-08-15 |
PublicationDate_xml | – month: 08 year: 2016 text: 2016-08-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | OXFORD |
PublicationPlace_xml | – name: OXFORD – name: England |
PublicationTitle | Bioorganic & medicinal chemistry |
PublicationTitleAbbrev | BIOORGAN MED CHEM |
PublicationTitleAlternate | Bioorg Med Chem |
PublicationYear | 2016 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | du Vigneaud, Winestock, Murti, Hope, Kimbrough, Hope, Murti, du Vigneaud, Manning, Stoev, Chini, Durroux, Mouillac, Guillon (b0095) 1960; 235 Striepens, Kendrick, Maier, Hurlemann (b0005) 2011; 32 Choc (b0070) 1997; 36 Budesinsky, Prochazka, Slaninova, Wittelsberger, Patiny, Slaninova, Barberis, Mutter (b0100) 2005; 12 Pitman, Orr, Lasko (b0035) 1993; 48 Deber, Bovey, Carver, Blout (b0105) 1970; 92 Gasteiger, Rudolph, Sadowski (b0110) 1990; 3 Goetz, Philippe, Shapiro, Goetz, Farrell, Shalaeva, Sciabola, Anderson, Yan, Philippe, Shapiro (b0065) 2014; 5 Hamman, Enslin, Kotze, Fasinu, Pillay, Ndesendo, du Toit, Choonara (b0055) 2005; 19 Feifel, Macdonald, Nguyen, Cobb, Warlan, Galangue, Minassian, Becker, Cooper, Perry, Lefebvre, Gonzales, Hadley (b0030) 2010; 68 Baumgartner, Heinrichs, Vonlanthen, Fischbacher, Fehr (b0015) 2008; 58 Craik, Fairlie, Liras, Price, Bock, Gavenonis, Kritzer, Beck, Chatterjee, Laufer, Kiran, Frank, Neubauer, Ovadia, Greenberg, Gilon, Hoffman, Kessler, Ovadia, Greenberg, Chatterjee, Laufer, Opperer, Kessler, Gilon, Hoffman (b0075) 2013; 81 Biron, Chatterjee, Ovadia, Langenegger, Brueggen, Hoyer, Schmid, Jelinek, Gilon, Hoffman, Kessler, Chatterjee, Gilon, Hoffman, Kessler (b0085) 2008; 47 De Dreu, Greer, Handgraaf, Shalvi, Van Kleef, Baas, Ten Velden, Van Dijk, Feith, Zak, Stanton, Ahmadi (b0020) 2010; 328 Tang, Persky, Hochhaus, Meibohm (b0050) 2004; 93 Onufriev, Bashford, Case (b0115) 2004; 55 Hollander, Novotny, Hanratty, Yaffe, DeCaria, Aronowitz, Mosovich, Hollander, Bartz, Chaplin, Phillips, Sumner, Soorya, Anagnostou, Wasserman (b0040) 2003; 28 Fesik, Gampe, Eaton, Gemmecker, Olejniczak, Neri, Holzman, Egan, Edalji, Loosli, Kesslerb, Oschkinatb, Weber, Petchera, Widmera (b0060) 1991; 30 Wood, Tickle, Treharne, Pitts, Mascarenhas, Li, Husain, Cooper, Blundell, Hruby, Urry, Ohnishi, Walter, Ohno, Kawasaki, Fukuhara, Okuda, Yamaguchi, Bhaskaran, Chuang, Yu, Ballardin, Fischman, Gibbons, Roy, Schwartz, Smith, Walter, Wyssbrod, Kato, Endo, Fujiwara, Nagayama, Urry, Walter (b0090) 1986; 232 Buchheim, Heinrichs, George, Pokorny, Koops, Henningsen, O’Connor, Gundel (b0010) 2009; 34 Domes, Lischke, Berger, Grossmann, Hauenstein, Heinrichs, Herpertz (b0025) 2010; 35 Liu, Malerba, Paoletti, Capsoni, Cattaneo (b0045) 2011; 8 Alex, Millan, Perez, Wakenhut, Whitlock, Bockus, Lexa, Pye, Kalgutkar, Gardner, Hund, Hewitt, Schwochert, Glassey, Price, Mathiowetz, Liras, Jacobson, Lokey (b0080) 2011; 2 Hollander, E (WOS:000180796400022) 2003; 28 BHASKARAN, R (WOS:A1992JZ64900002) 1992; 32 Domes, G (WOS:000273844100009) 2010; 35 Beck, JG (WOS:000306724500060) 2012; 134 Ovadia, O (WOS:000289008600017) 2011; 8 Gasteiger, J. (000380515700020.21) 1990; 3 Fasinu, P (WOS:000290491100001) 2011; 32 Onufriev, A (WOS:000220980600016) 2004; 55 Buchheim, A (WOS:000270777500016) 2009; 34 DEBER, CM (WOS:A1970H557400016) 1970; 92 Hamman, JH (WOS:000230829000003) 2005; 19 Bock, JE (WOS:000316375500002) 2013; 8 Malerba, F (WOS:000295330300004) 2011; 8 Manning, M. (000380515700020.31) 1000 Wittelsberger, A (WOS:000232781600004) 2005; 48 De Dreu, CKW (WOS:000278598400042) 2010; 328 Choc, MG (WOS:000071617200001) 1997; 36 URRY, DW (WOS:A1971J330200021) 1971; 68 Tang, L (WOS:000223561900002) 2004; 93 Liu, XF (WOS:000297224500010) 2011; 8 WOOD, SP (WOS:A1986C034500027) 1986; 232 Craik, DJ (WOS:000312546000015) 2013; 81 Hollander, E (WOS:000244344400011) 2007; 61 HOPE, DB (WOS:A19623975B00020) 1962; 237 Baumgartner, T (WOS:000256120500016) 2008; 58 PITMAN, RK (WOS:A1993LX20700002) 1993; 48 Goetz, GH (WOS:000334572000011) 2014; 57 Alex, A (WOS:000293316800018) 2011; 2 Chatterjee, J (WOS:000260254300011) 2008; 41 Feifel, D (WOS:000282356900015) 2010; 68 KATO, T (WOS:A1993MK83000004) 1993; 3 DUVIGNEAUD, V (WOS:A1960WA43300062) 1960; 235 Zak, PJ (WOS:000207459000012) 2007; 2 Ohno, A (WOS:000273900400013) 2010; 48 Biron, E (WOS:000254869800009) 2008; 47 Bockus, AT (WOS:000356316600013) 2015; 58 FESIK, SW (WOS:A1991FU89800030) 1991; 30 BALLARDIN, A (WOS:A1978FT40200014) 1978; 17 URRY, DW (WOS:A1970G471700018) 1970; 66 LOOSLI, HR (WOS:A1985AHM9600018) 1985; 68 Striepens, N (WOS:000295556000005) 2011; 32 Goetz, GH (WOS:000343016700020) 2014; 5 Budesinsky, M (WOS:000229162900008) 2005; 12 Goetz (10.1016/j.bmc.2016.05.062_h0095) 2014; 57 Beck (10.1016/j.bmc.2016.05.062_h0115) 2012; 134 Ovadia (10.1016/j.bmc.2016.05.062_h0120) 2011; 8 Gasteiger (10.1016/j.bmc.2016.05.062_b0110) 1990; 3 Zak (10.1016/j.bmc.2016.05.062_h0025) 2007; 2 Fasinu (10.1016/j.bmc.2016.05.062_h0075) 2011; 32 Hollander (10.1016/j.bmc.2016.05.062_h0050) 2007; 61 Hamman (10.1016/j.bmc.2016.05.062_h0070) 2005; 19 Wood (10.1016/j.bmc.2016.05.062_h0145) 1986; 232 Urry (10.1016/j.bmc.2016.05.062_h0175) 1971; 68 Budesinsky (10.1016/j.bmc.2016.05.062_h0195) 2005; 12 Deber (10.1016/j.bmc.2016.05.062_b0105) 1970; 92 Urry (10.1016/j.bmc.2016.05.062_h0150) 1970; 66 Wittelsberger (10.1016/j.bmc.2016.05.062_h0200) 2005; 48 Choc (10.1016/j.bmc.2016.05.062_b0070) 1997; 36 Tang (10.1016/j.bmc.2016.05.062_b0050) 2004; 93 Feifel (10.1016/j.bmc.2016.05.062_b0030) 2010; 68 Fesik (10.1016/j.bmc.2016.05.062_h0080) 1991; 30 Biron (10.1016/j.bmc.2016.05.062_h0135) 2008; 47 Pitman (10.1016/j.bmc.2016.05.062_b0035) 1993; 48 Bhaskaran (10.1016/j.bmc.2016.05.062_h0160) 1992; 32 Onufriev (10.1016/j.bmc.2016.05.062_b0115) 2004; 55 Liu (10.1016/j.bmc.2016.05.062_h0055) 2011; 8 Ballardin (10.1016/j.bmc.2016.05.062_h0165) 1978; 17 du Vigneaud (10.1016/j.bmc.2016.05.062_h0180) 1960; 235 Ohno (10.1016/j.bmc.2016.05.062_h0155) 2010; 48 Bockus (10.1016/j.bmc.2016.05.062_h0130) 2015; 58 Striepens (10.1016/j.bmc.2016.05.062_b0005) 2011; 32 Hollander (10.1016/j.bmc.2016.05.062_h0045) 2003; 28 Manning (10.1016/j.bmc.2016.05.062_h0190) 2008; Vol. 170 Buchheim (10.1016/j.bmc.2016.05.062_b0010) 2009; 34 Craik (10.1016/j.bmc.2016.05.062_h0105) 2013; 81 Hope (10.1016/j.bmc.2016.05.062_h0185) 1962; 237 Chatterjee (10.1016/j.bmc.2016.05.062_h0140) 2008; 41 Kato (10.1016/j.bmc.2016.05.062_h0170) 1993; 3 Domes (10.1016/j.bmc.2016.05.062_b0025) 2010; 35 Malerba (10.1016/j.bmc.2016.05.062_h0060) 2011; 8 Goetz (10.1016/j.bmc.2016.05.062_h0090) 2014; 5 De Dreu (10.1016/j.bmc.2016.05.062_h0020) 2010; 328 Loosli (10.1016/j.bmc.2016.05.062_h0085) 1985; 68 Bock (10.1016/j.bmc.2016.05.062_h0110) 2012; 8 Baumgartner (10.1016/j.bmc.2016.05.062_b0015) 2008; 58 Alex (10.1016/j.bmc.2016.05.062_h0125) 2011; 2 |
References_xml | – volume: 68 start-page: 678 year: 2010 ident: b0030 publication-title: Biol. Psychiatry contributor: fullname: Hadley – volume: 35 start-page: 83 year: 2010 ident: b0025 publication-title: Psychoneuroendocrinology contributor: fullname: Herpertz – volume: 48 start-page: 107 year: 1993 ident: b0035 publication-title: Psychiatry Res. contributor: fullname: Lasko – volume: 55 start-page: 383 year: 2004 ident: b0115 publication-title: Proteins contributor: fullname: Case – volume: 58 start-page: 639 year: 2008 ident: b0015 publication-title: Neuron contributor: fullname: Fehr – volume: 2 start-page: 669 year: 2011 ident: b0080 publication-title: MedChemComm contributor: fullname: Lokey – volume: 47 start-page: 2595 year: 2008 ident: b0085 publication-title: Angew. Chem., Int. Ed. contributor: fullname: Kessler – volume: 93 start-page: 2184 year: 2004 ident: b0050 publication-title: J. Pharm. Sci. contributor: fullname: Meibohm – volume: 3 start-page: 537 year: 1990 ident: b0110 publication-title: Tetrahedron Comput. Methodol. contributor: fullname: Sadowski – volume: 19 start-page: 165 year: 2005 ident: b0055 publication-title: BioDrugs contributor: fullname: Choonara – volume: 5 start-page: 1167 year: 2014 ident: b0065 publication-title: ACS Med. Chem. Lett. contributor: fullname: Shapiro – volume: 34 start-page: 1417 year: 2009 ident: b0010 publication-title: Psychoneuroendocrinology contributor: fullname: Gundel – volume: 81 start-page: 136 year: 2013 ident: b0075 publication-title: Chem. Biol. Drug Des. contributor: fullname: Hoffman – volume: 235 start-page: PC64 year: 1960 end-page: 512 ident: b0095 article-title: Peptide and Non-Peptide Agonists and Antagonists for the Vasopressin and Oxytocin V1a, V1b, V2 and OT Receptors: Research Tools and Potential Therapeutic Agents publication-title: J. Biol. Chem. contributor: fullname: Guillon – volume: 8 start-page: 1681 year: 2011 ident: b0045 publication-title: Expert Opin. Drug Deliv. contributor: fullname: Cattaneo – volume: 30 start-page: 6574 year: 1991 ident: b0060 publication-title: Biochemistry contributor: fullname: Widmera – volume: 92 start-page: 6191 year: 1970 ident: b0105 publication-title: J. Am. Chem. Soc. contributor: fullname: Blout – volume: 32 start-page: 426 year: 2011 ident: b0005 publication-title: Front. Neuroendocrinol. contributor: fullname: Hurlemann – volume: 328 start-page: 1408 year: 2010 ident: b0020 publication-title: Science contributor: fullname: Ahmadi – volume: 28 start-page: 193 year: 2003 ident: b0040 publication-title: Neuropsychopharmacology contributor: fullname: Wasserman – volume: 232 start-page: 633 year: 1986 ident: b0090 publication-title: Science contributor: fullname: Walter – volume: 12 start-page: 343 year: 2005 ident: b0100 publication-title: Protein Pept. Lett. contributor: fullname: Mutter – volume: 36 start-page: 1 year: 1997 ident: b0070 publication-title: Int. J. Dermatol. contributor: fullname: Choc – volume: 35 start-page: 83 year: 2010 ident: WOS:000273844100009 article-title: Effects of intranasal oxytocin on emotional face processing in women publication-title: PSYCHONEUROENDOCRINOLOGY doi: 10.1016/j.psyneuen.2009.06.016 contributor: fullname: Domes, G – volume: 5 start-page: 1167 year: 2014 ident: WOS:000343016700020 article-title: EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides publication-title: ACS MEDICINAL CHEMISTRY LETTERS doi: 10.1021/ml500239m contributor: fullname: Goetz, GH – volume: 58 start-page: 639 year: 2008 ident: WOS:000256120500016 article-title: Oxytocin shapes the neural circuitry of trust and trust adaptation in humans publication-title: NEURON doi: 10.1016/j.neuron.2008.04.009 contributor: fullname: Baumgartner, T – volume: 235 start-page: PC64 year: 1960 ident: WOS:A1960WA43300062 article-title: SYNTHESIS OF 1-BETA-MERCAPTOPROPIONIC ACID OXYTOCIN (DESAMINO-OXYTOCIN), A HIGHLY POTENT ANALOGUE OF OXYTOCIN publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY contributor: fullname: DUVIGNEAUD, V – volume: 34 start-page: 1417 year: 2009 ident: WOS:000270777500016 article-title: Oxytocin enhances the experience of attachment security publication-title: PSYCHONEUROENDOCRINOLOGY doi: 10.1016/j.psyneuen.2009.04.002 contributor: fullname: Buchheim, A – volume: 3 start-page: 537 year: 1990 ident: 000380515700020.21 article-title: Automatic Generation of 3D-Atomic Coordinates for Organic Molecules publication-title: Tetrahedron Comput. Methodol. contributor: fullname: Gasteiger, J. – volume: 3 start-page: 653 year: 1993 ident: WOS:A1993MK83000004 article-title: OXYTOCIN SOLUTION STRUCTURE CHANGES UPON PROTONATION OF THE N-TERMINUS IN DIMETHYL-SULFOXIDE publication-title: JOURNAL OF BIOMOLECULAR NMR contributor: fullname: KATO, T – volume: 237 start-page: 1563 year: 1962 ident: WOS:A19623975B00020 article-title: HIGHLY POTENT ANALOGUE OF OXYTOCIN, DESAMINO-OXYTOCINO-OXYTOCIN publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY contributor: fullname: HOPE, DB – volume: 8 start-page: 1681 year: 2011 ident: WOS:000297224500010 article-title: Clinical trials of intranasal delivery for treating neurological disorders - a critical review publication-title: EXPERT OPINION ON DRUG DELIVERY doi: 10.1517/17425247.2011.633508 contributor: fullname: Liu, XF – volume: 32 start-page: 185 year: 2011 ident: WOS:000290491100001 article-title: Diverse approaches for the enhancement of oral drug bioavailability publication-title: BIOPHARMACEUTICS & DRUG DISPOSITION doi: 10.1002/bdd.750 contributor: fullname: Fasinu, P – volume: 17 start-page: 4443 year: 1978 ident: WOS:A1978FT40200014 article-title: CONFORMATIONAL STUDIES ON [PRO3,GLY4]-OXYTOCIN IN DIMETHYL-SULFOXIDE BY H-1 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY - EVIDENCE FOR A TYPE-II BETA-TURN IN CYCLIC MOIETY publication-title: BIOCHEMISTRY contributor: fullname: BALLARDIN, A – volume: 48 start-page: 107 year: 1993 ident: WOS:A1993LX20700002 article-title: EFFECTS OF INTRANASAL VASOPRESSIN AND OXYTOCIN ON PHYSIOLOGICAL RESPONDING DURING PERSONAL COMBAT IMAGERY IN VIETNAM VETERANS WITH POSTTRAUMATIC-STRESS-DISORDER publication-title: PSYCHIATRY RESEARCH contributor: fullname: PITMAN, RK – volume: 57 start-page: 2920 year: 2014 ident: WOS:000334572000011 article-title: High Throughput Method for the Indirect Detection of Intramolecular Hydrogen Bonding publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm401859b contributor: fullname: Goetz, GH – volume: 68 start-page: 956 year: 1971 ident: WOS:A1971J330200021 article-title: PROPOSED CONFORMATION OF OXYTOCIN IN SOLUTION publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA contributor: fullname: URRY, DW – volume: 48 start-page: 168 year: 2010 ident: WOS:000273900400013 article-title: Complete NMR analysis of oxytocin in phosphate buffer publication-title: MAGNETIC RESONANCE IN CHEMISTRY doi: 10.1002/mrc.2557 contributor: fullname: Ohno, A – volume: 19 start-page: 165 year: 2005 ident: WOS:000230829000003 article-title: Oral delivery of peptide drugs - Barriers and developments publication-title: BIODRUGS contributor: fullname: Hamman, JH – volume: 36 start-page: 1 year: 1997 ident: WOS:000071617200001 article-title: Bioavailability and pharmacokinetics of cyclosporine formulations: Neoral (R) vs Sandimmune (R) publication-title: INTERNATIONAL JOURNAL OF DERMATOLOGY contributor: fullname: Choc, MG – volume: 68 start-page: 682 year: 1985 ident: WOS:A1985AHM9600018 article-title: PEPTIDE CONFORMATIONS .31. THE CONFORMATION OF CYCLOSPORIN-A IN THE CRYSTAL AND IN SOLUTION publication-title: HELVETICA CHIMICA ACTA contributor: fullname: LOOSLI, HR – volume: 28 start-page: 193 year: 2003 ident: WOS:000180796400022 article-title: Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders publication-title: NEUROPSYCHOPHARMACOLOGY doi: 10.1038/sj.npp.1300021 contributor: fullname: Hollander, E – volume: 2 start-page: ARTN e1128 year: 2007 ident: WOS:000207459000012 article-title: Oxytocin Increases Generosity in Humans publication-title: PLOS ONE doi: 10.1371/journal.pone.0001128 contributor: fullname: Zak, PJ – volume: 328 start-page: 1408 year: 2010 ident: WOS:000278598400042 article-title: The Neuropeptide Oxytocin Regulates Parochial Altruism in Intergroup Conflict Among Humans publication-title: SCIENCE doi: 10.1126/science.1189047 contributor: fullname: De Dreu, CKW – volume: 58 start-page: 4581 year: 2015 ident: WOS:000356316600013 article-title: Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.5b00128 contributor: fullname: Bockus, AT – volume: 30 start-page: 6574 year: 1991 ident: WOS:A1991FU89800030 article-title: NMR-STUDIES OF [U-C-13]CYCLOSPORIN-A BOUND TO CYCLOPHILIN - BOUND CONFORMATION AND PORTIONS OF CYCLOSPORINE INVOLVED IN BINDING publication-title: BIOCHEMISTRY contributor: fullname: FESIK, SW – volume: 66 start-page: 111 year: 1970 ident: WOS:A1970G471700018 article-title: SECONDARY STRUCTURE OF CYCLIC MOIETY OF PEPTIDE HORMONE OXYTOCIN AND ITS DEAMINO ANALOG publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA contributor: fullname: URRY, DW – volume: 32 start-page: 1599 year: 1992 ident: WOS:A1992JZ64900002 article-title: CONFORMATIONAL PROPERTIES OF OXYTOCIN IN DIMETHYL-SULFOXIDE SOLUTION - NMR AND RESTRAINED MOLECULAR-DYNAMICS STUDIES publication-title: BIOPOLYMERS contributor: fullname: BHASKARAN, R – volume: 12 start-page: 343 year: 2005 ident: WOS:000229162900008 article-title: Oxytocin and its analogs, methyl-substituted in ortho-, meta- or para-position of aromatic ring of phenylalanine in position 2: NMR study and biological activities publication-title: PROTEIN AND PEPTIDE LETTERS contributor: fullname: Budesinsky, M – volume: 2 start-page: 669 year: 2011 ident: WOS:000293316800018 article-title: Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space publication-title: MEDCHEMCOMM doi: 10.1039/c1md00093d contributor: fullname: Alex, A – volume: 41 start-page: 1331 year: 2008 ident: WOS:000260254300011 article-title: N-Methylation of Peptides: A New Perspective in Medicinal Chemistry publication-title: ACCOUNTS OF CHEMICAL RESEARCH doi: 10.1021/ar8000603 contributor: fullname: Chatterjee, J – volume: 48 start-page: 6553 year: 2005 ident: WOS:000232781600004 article-title: Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm049205z contributor: fullname: Wittelsberger, A – volume: 134 start-page: 12125 year: 2012 ident: WOS:000306724500060 article-title: Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja303200d contributor: fullname: Beck, JG – volume: 68 start-page: 678 year: 2010 ident: WOS:000282356900015 article-title: Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia Patients publication-title: BIOLOGICAL PSYCHIATRY doi: 10.1016/j.biopsych.2010.04.039 contributor: fullname: Feifel, D – volume: 8 start-page: 488 year: 2013 ident: WOS:000316375500002 article-title: Getting in Shape: Controlling Peptide Bioactivity and Bioavailability Using Conformational Constraints publication-title: ACS CHEMICAL BIOLOGY doi: 10.1021/cb300515u contributor: fullname: Bock, JE – volume: 92 start-page: 6191 year: 1970 ident: WOS:A1970H557400016 article-title: NUCLEAR MAGNETIC RESONANCE EVIDENCE FOR CIS-PEPTIDE BONDS IN PROLINE OLIGOMERS publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY contributor: fullname: DEBER, CM – volume: 81 start-page: 136 year: 2013 ident: WOS:000312546000015 article-title: The Future of Peptide-based Drugs publication-title: CHEMICAL BIOLOGY & DRUG DESIGN doi: 10.1111/cbdd.12055 contributor: fullname: Craik, DJ – volume: 93 start-page: 2184 year: 2004 ident: WOS:000223561900002 article-title: Pharmacokinetic aspects of biotechnology products publication-title: JOURNAL OF PHARMACEUTICAL SCIENCES doi: 10.1002/jps.20125 contributor: fullname: Tang, L – volume: 8 start-page: 1277 year: 2011 ident: WOS:000295330300004 article-title: Intranasal delivery of therapeutic proteins for neurological diseases publication-title: EXPERT OPINION ON DRUG DELIVERY doi: 10.1517/17425247.2011.588204 contributor: fullname: Malerba, F – volume: 47 start-page: 2595 year: 2008 ident: WOS:000254869800009 article-title: Improving oral bioavailability of peptides by multiple N-methylation: Somatostatin analogues publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION doi: 10.1002/anie.200705797 contributor: fullname: Biron, E – volume: 55 start-page: 383 year: 2004 ident: WOS:000220980600016 article-title: Exploring protein native states and large-scale conformational changes with a modified generalized born model publication-title: PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS doi: 10.1002/prot.20033 contributor: fullname: Onufriev, A – year: 1000 ident: 000380515700020.31 article-title: Peptide and Non-Peptide Agonists and Antagonists for the Vasopressin and Oxytocin V1a, V1b, V2 and OT Receptors: Research Tools and Potential Therapeutic Agents publication-title: Progress in Brain Research contributor: fullname: Manning, M. – volume: 232 start-page: 633 year: 1986 ident: WOS:A1986C034500027 article-title: CRYSTAL-STRUCTURE ANALYSIS OF DEAMINO-OXYTOCIN - CONFORMATIONAL FLEXIBILITY AND RECEPTOR-BINDING publication-title: SCIENCE contributor: fullname: WOOD, SP – volume: 61 start-page: 498 year: 2007 ident: WOS:000244344400011 article-title: Oxytocin increases retention of social cognition in autism publication-title: BIOLOGICAL PSYCHIATRY doi: 10.1016/j.biopsych.2006.05.030 contributor: fullname: Hollander, E – volume: 32 start-page: 426 year: 2011 ident: WOS:000295556000005 article-title: Prosocial effects of oxytocin and clinical evidence for its therapeutic potential publication-title: FRONTIERS IN NEUROENDOCRINOLOGY doi: 10.1016/j.yfrne.2011.07.001 contributor: fullname: Striepens, N – volume: 8 start-page: 479 year: 2011 ident: WOS:000289008600017 article-title: The Effect of Multiple N-Methylation on Intestinal Permeability of Cyclic Hexapeptides publication-title: MOLECULAR PHARMACEUTICS doi: 10.1021/mp1003306 contributor: fullname: Ovadia, O – volume: 8 start-page: 488 year: 2012 ident: 10.1016/j.bmc.2016.05.062_h0110 publication-title: ACS Chem. Biol. doi: 10.1021/cb300515u contributor: fullname: Bock – volume: 328 start-page: 1408 year: 2010 ident: 10.1016/j.bmc.2016.05.062_h0020 publication-title: Science doi: 10.1126/science.1189047 contributor: fullname: De Dreu – volume: 48 start-page: 107 year: 1993 ident: 10.1016/j.bmc.2016.05.062_b0035 publication-title: Psychiatry Res. doi: 10.1016/0165-1781(93)90035-F contributor: fullname: Pitman – volume: 36 start-page: 1 year: 1997 ident: 10.1016/j.bmc.2016.05.062_b0070 publication-title: Int. J. Dermatol. doi: 10.1046/j.1365-4362.36.s1.2.x contributor: fullname: Choc – volume: 92 start-page: 6191 year: 1970 ident: 10.1016/j.bmc.2016.05.062_b0105 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00724a016 contributor: fullname: Deber – volume: 12 start-page: 343 year: 2005 ident: 10.1016/j.bmc.2016.05.062_h0195 publication-title: Protein Pept. Lett. doi: 10.2174/0929866053765752 contributor: fullname: Budesinsky – volume: 8 start-page: 1277 year: 2011 ident: 10.1016/j.bmc.2016.05.062_h0060 publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2011.588204 contributor: fullname: Malerba – volume: 30 start-page: 6574 year: 1991 ident: 10.1016/j.bmc.2016.05.062_h0080 publication-title: Biochemistry doi: 10.1021/bi00240a030 contributor: fullname: Fesik – volume: 68 start-page: 678 year: 2010 ident: 10.1016/j.bmc.2016.05.062_b0030 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2010.04.039 contributor: fullname: Feifel – volume: 8 start-page: 1681 year: 2011 ident: 10.1016/j.bmc.2016.05.062_h0055 publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2011.633508 contributor: fullname: Liu – volume: 32 start-page: 185 year: 2011 ident: 10.1016/j.bmc.2016.05.062_h0075 publication-title: Biopharm. Drug Dispos. doi: 10.1002/bdd.750 contributor: fullname: Fasinu – volume: 237 start-page: 1563 year: 1962 ident: 10.1016/j.bmc.2016.05.062_h0185 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)83740-7 contributor: fullname: Hope – volume: 34 start-page: 1417 year: 2009 ident: 10.1016/j.bmc.2016.05.062_b0010 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2009.04.002 contributor: fullname: Buchheim – volume: 61 start-page: 498 year: 2007 ident: 10.1016/j.bmc.2016.05.062_h0050 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2006.05.030 contributor: fullname: Hollander – volume: 66 start-page: 111 year: 1970 ident: 10.1016/j.bmc.2016.05.062_h0150 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.66.1.111 contributor: fullname: Urry – volume: 232 start-page: 633 year: 1986 ident: 10.1016/j.bmc.2016.05.062_h0145 publication-title: Science doi: 10.1126/science.3008332 contributor: fullname: Wood – volume: 81 start-page: 136 year: 2013 ident: 10.1016/j.bmc.2016.05.062_h0105 publication-title: Chem. Biol. Drug Des. doi: 10.1111/cbdd.12055 contributor: fullname: Craik – volume: 41 start-page: 1331 year: 2008 ident: 10.1016/j.bmc.2016.05.062_h0140 publication-title: Acc. Chem. Res. doi: 10.1021/ar8000603 contributor: fullname: Chatterjee – volume: 68 start-page: 682 year: 1985 ident: 10.1016/j.bmc.2016.05.062_h0085 publication-title: Helv. Chim. Acta doi: 10.1002/hlca.19850680319 contributor: fullname: Loosli – volume: 35 start-page: 83 year: 2010 ident: 10.1016/j.bmc.2016.05.062_b0025 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2009.06.016 contributor: fullname: Domes – volume: 58 start-page: 639 year: 2008 ident: 10.1016/j.bmc.2016.05.062_b0015 publication-title: Neuron doi: 10.1016/j.neuron.2008.04.009 contributor: fullname: Baumgartner – volume: 5 start-page: 1167 year: 2014 ident: 10.1016/j.bmc.2016.05.062_h0090 publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml500239m contributor: fullname: Goetz – volume: 58 start-page: 4581 year: 2015 ident: 10.1016/j.bmc.2016.05.062_h0130 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b00128 contributor: fullname: Bockus – volume: 55 start-page: 383 year: 2004 ident: 10.1016/j.bmc.2016.05.062_b0115 publication-title: Proteins doi: 10.1002/prot.20033 contributor: fullname: Onufriev – volume: 32 start-page: 426 year: 2011 ident: 10.1016/j.bmc.2016.05.062_b0005 publication-title: Front. Neuroendocrinol. doi: 10.1016/j.yfrne.2011.07.001 contributor: fullname: Striepens – volume: 235 start-page: PC64 year: 1960 ident: 10.1016/j.bmc.2016.05.062_h0180 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)64530-2 contributor: fullname: du Vigneaud – volume: Vol. 170 start-page: 473 year: 2008 ident: 10.1016/j.bmc.2016.05.062_h0190 article-title: Peptide and Non-Peptide Agonists and Antagonists for the Vasopressin and Oxytocin V1a, V1b, V2 and OT Receptors: Research Tools and Potential Therapeutic Agents contributor: fullname: Manning – volume: 8 start-page: 479 year: 2011 ident: 10.1016/j.bmc.2016.05.062_h0120 publication-title: Mol. Pharm. doi: 10.1021/mp1003306 contributor: fullname: Ovadia – volume: 2 start-page: 669 year: 2011 ident: 10.1016/j.bmc.2016.05.062_h0125 publication-title: MedChemComm doi: 10.1039/c1md00093d contributor: fullname: Alex – volume: 134 start-page: 12125 year: 2012 ident: 10.1016/j.bmc.2016.05.062_h0115 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja303200d contributor: fullname: Beck – volume: 28 start-page: 193 year: 2003 ident: 10.1016/j.bmc.2016.05.062_h0045 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300021 contributor: fullname: Hollander – volume: 3 start-page: 537 year: 1990 ident: 10.1016/j.bmc.2016.05.062_b0110 publication-title: Tetrahedron Comput. Methodol. doi: 10.1016/0898-5529(90)90156-3 contributor: fullname: Gasteiger – volume: 2 start-page: e1128 year: 2007 ident: 10.1016/j.bmc.2016.05.062_h0025 publication-title: PLoS One doi: 10.1371/journal.pone.0001128 contributor: fullname: Zak – volume: 93 start-page: 2184 year: 2004 ident: 10.1016/j.bmc.2016.05.062_b0050 publication-title: J. Pharm. Sci. doi: 10.1002/jps.20125 contributor: fullname: Tang – volume: 3 start-page: 653 year: 1993 ident: 10.1016/j.bmc.2016.05.062_h0170 publication-title: J. Biomol. NMR doi: 10.1007/BF00198370 contributor: fullname: Kato – volume: 48 start-page: 6553 year: 2005 ident: 10.1016/j.bmc.2016.05.062_h0200 publication-title: J. Med. Chem. doi: 10.1021/jm049205z contributor: fullname: Wittelsberger – volume: 19 start-page: 165 year: 2005 ident: 10.1016/j.bmc.2016.05.062_h0070 publication-title: BioDrugs doi: 10.2165/00063030-200519030-00003 contributor: fullname: Hamman – volume: 32 start-page: 1599 year: 1992 ident: 10.1016/j.bmc.2016.05.062_h0160 publication-title: Biopolymers doi: 10.1002/bip.360321203 contributor: fullname: Bhaskaran – volume: 68 start-page: 956 year: 1971 ident: 10.1016/j.bmc.2016.05.062_h0175 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.68.5.956 contributor: fullname: Urry – volume: 47 start-page: 2595 year: 2008 ident: 10.1016/j.bmc.2016.05.062_h0135 publication-title: Angew. Chem., Int. Ed. doi: 10.1002/anie.200705797 contributor: fullname: Biron – volume: 48 start-page: 168 year: 2010 ident: 10.1016/j.bmc.2016.05.062_h0155 publication-title: Magn. Reson. Chem. contributor: fullname: Ohno – volume: 57 start-page: 2920 year: 2014 ident: 10.1016/j.bmc.2016.05.062_h0095 publication-title: J. Med. Chem. doi: 10.1021/jm401859b contributor: fullname: Goetz – volume: 17 start-page: 4443 year: 1978 ident: 10.1016/j.bmc.2016.05.062_h0165 publication-title: Biochemistry doi: 10.1021/bi00614a014 contributor: fullname: Ballardin |
SSID | ssj0002491 |
Score | 2.3666859 |
Snippet | [Display omitted]
Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding,... Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and... |
Source | Web of Science |
SourceID | proquest crossref pubmed webofscience elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3513 |
SubjectTerms | Biochemistry & Molecular Biology Chemistry Chemistry, Medicinal Chemistry, Organic Cyclic peptide Hidden polarity Hydrogen Bonding Intramolecular hydrogen bond Life Sciences & Biomedicine Magnetic Resonance Spectroscopy Methylation NMR Oxytocin Oxytocin - chemistry Peptide Pharmacology & Pharmacy Physical Sciences Polarity Science & Technology SFC Structure-Activity Relationship Temperature |
Title | Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network |
URI | https://dx.doi.org/10.1016/j.bmc.2016.05.062 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000380515700020 https://www.ncbi.nlm.nih.gov/pubmed/27297999 https://search.proquest.com/docview/1805766976 |
Volume | 24 |
WOS | 000380515700020 |
WOSCitedRecordID | wos000380515700020 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SBNpeSrvpw30EFUIPBXdlr621eluWhk1Lc0kDuQk9bLKBtZfUgewlv72fZHvb0gelF4PlB7I-eeYbzWiG6DDRFUgD_m8jbRZnU2FiKWGlWF7BfNaVEWWI8j0Ri7Ps43l-vkPzYS-MD6vsZX8n04O07lvG_WiO18vl-BTku-CFFGAUmIkCdvse1JH31e7Njj8tTrYCGRZGKJyH-2P_wODcDGFeZuUTGSYi5O8U6Z_U06_087eaKmilo4f0oKeTbNb1-BHtlPWI9mc1TOnVhr1hIcAzrJyP6N58KO42orufe5_6Pl2cbpM5M4jVEsh18XGsqVhzs2kBX_2eHYftlAzN6-_ZrjdM144t_QLxaqizyy427qrBvGSmCVtmWN2Fmj-ms6MPX-aLuK-_ENsskW1cGZ5qDrSsldoJ7g8O2OYuM979VyVSFzZHQybtxLlKg1_kMJAK0DqX2skT2q2bunxGjMvUCKNtakvwCbydywmv8Ho9BUObuIjeDsOu1l2aDTXEn10qYKQ8RornChhFlA3AqJ_mioIa-NtjrwcQFUbbO0Z0XTbXX1VSgLUKAWYW0dMO3W0vUlgfU7DoiA5_hHt7PfhWfaGcafDqRpT8y23zPgG7TzzQPv-_73lB9_2ZX-BO8pe0215dl6_AkFpzQHfe3SYH_X_wDeE2DoQ |
link.rule.ids | 314,780,784,4502,24116,27924,27925,45585,45679 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CCk0vpd304T5VCD0U3JW9ttbqLSwNmzbJJQnkJvSwyQbWXlIHupf-9n6S7U1LH5RefJBlIesbSd9oRjNEe4muQBowv420WZxNhYmlhJZieQX1WVdGlMHL90TMz7NPF_nFFs2GuzDerbJf-7s1PazWfcm4H83xarEYn4J8F7yQAowCkiigt9_JcrBfCPX7b7d-HtAvQto81I599cG0GZy8zNKHMUxEiN4p0j9tTr-Sz9_uU2FPOnhA93syyfa7_j6krbIe0e5-DUV6uWZvWXDvDOfmI9qZDandRnT3uLeo79Ll6SaUM8OiWgK3zjuONRVrvq5bgFd_YIfhMiVD8eo21vWa6dqxhT8eXg5Zdtnl2l03kEpmmnBhhtWdo_kjOj_4eDabx332hdhmiWzjyvBUc2BlrdROcP9wQDZ3mfHGvyqRurA5CjJpJ85VGuwih3pUgNS51E4e03bd1OVTYlymRhhtU1uCTaB1Lie8QvN6Cn42cRG9G4ZdrbogG2rwPrtSwEh5jBTPFTCKKBuAUT9JisIm8LfP3gwgKoy2N4voumxuvqikAGcVArwsoicduptepNA9puDQEe39CPfmfbCs-jQ502DTjSj5l2qzPvy6DzvQPvu__3lNO_Oz4yN1dHjy-Tnd82_8UXeSv6Dt9vqmfAmu1JpXYS58B1cRD10 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systematic+N-methylation+of+oxytocin%3A+Impact+on+pharmacology+and+intramolecular+hydrogen+bonding+network&rft.jtitle=Bioorganic+%26+medicinal+chemistry&rft.au=Sciabola%2C+Simone&rft.au=Goetz%2C+Gilles+H.&rft.au=Bai%2C+Guoyun&rft.au=Rogers%2C+Bruce+N.&rft.date=2016-08-15&rft.pub=Elsevier&rft.issn=0968-0896&rft.eissn=1464-3391&rft.volume=24&rft.issue=16&rft.spage=3513&rft.epage=3520&rft_id=info:doi/10.1016%2Fj.bmc.2016.05.062&rft_id=info%3Apmid%2F27297999&rft.externalDBID=n%2Fa&rft.externalDocID=000380515700020 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0968-0896&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0968-0896&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0968-0896&client=summon |